# Tirzepatide for Alcohol Use Disorder

> **NCT06994338** · PHASE2 · RECRUITING · sponsor: **University of Southern California** · enrollment: 42 (estimated)

## Conditions studied

- Alcohol Use Disorder
- Obesity and Overweight
- Alcohol

## Interventions

- **DRUG:** Tirzepatide
- **DRUG:** Placebo injections

## Key facts

- **NCT ID:** NCT06994338
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-06
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2025-10-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06994338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06994338, "Tirzepatide for Alcohol Use Disorder". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06994338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*